Patents by Inventor Sandeep Pankajkumar PATHAK

Sandeep Pankajkumar PATHAK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SELECTIVE ESTROGEN RECEPTOR DEGRADER
    Publication number: 20210261534
    Abstract: A selective estrogen receptor degrader (SERD), a compound 3-(3,5-difluorophenyl)-2-[4-[(E)-3-[3-(fluoromethyl)azetidin-1-yl]prop-1-enyl]phenyl]-4-methyl-2H-chromen-7-ol, and its S enantiomer, (2S)-3-(3,5-difluorophenyl)-2-[4-[(E)-3-[3-(fluoromethyl)azetidin-1-yl]prop-1-enyl]phenyl]-4-methyl-2H-chromen-7-ol, or pharmaceutically acceptable salts thereof. Also provided are processes for their preparation. Also provided for is the use of these compounds for the treatment of diseases which are related to modulation of estrogen receptors, such as ER-positive breast cancer.
    Type: Application
    Filed: May 5, 2021
    Publication date: August 26, 2021
    Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
    Inventors: Ranjan Kumar PAL, Biswajit SAMANTA, Jayraj Dilipbhai ARADHYE, Sandeep Pankajkumar PATHAK, Kaushik Dhanjibhai PRAJAPATI, Bhavesh Mohanbhai PANCHAL, Trinadha Rao CHITTURI
  • Selective estrogen receptor degrader
    Patent number: 11014915
    Abstract: A selective estrogen receptor degrader (SERD), a compound 3-(3,5-difluorophenyl)-2-[4-[(E)-3-[3-(fluoromethyl)azetidin-1-yl]prop-1-enyl]phenyl]-4-methyl-2H-chromen-7-ol, and its S enantiomer, (2S)-3-(3,5-difluorophenyl)-2-[4-[(E)-3-[3-(fluoromethyl)azetidin-1-yl]prop-1-enyl]phenyl]-4-methyl-2H-chromen-7-ol, or pharmaceutically acceptable salts thereof. Also provided are processes for their preparation. Also provided for is the use of these compounds for the treatment of diseases which are related to modulation of estrogen receptors, such as ER-positive breast cancer.
    Type: Grant
    Filed: July 22, 2020
    Date of Patent: May 25, 2021
    Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
    Inventors: Rajan Kumar Pal, Biswajit Samanta, Jayraj Dilipbhai Aradhye, Sandeep Pankajkumar Pathak, Kaushik Dhanjibhai Prajapati, Bhavesh Mohanbhai Panchal, Trinadha Rao Chitturi
  • SELECTIVE ESTROGEN RECEPTOR DEGRADER
    Publication number: 20210024504
    Abstract: A selective estrogen receptor degrader (SERD), a compound 3-(3,5-difluorophenyl)-2-[4-[(E)-3-[3-(fluoromethyl)azetidin-1-yl]prop-1-enyl]phenyl]-4-methyl-2H-chromen-7-ol, and its S enantiomer, (2S)-3-(3,5-difluorophenyl)-2-[4-[(E)-3-[3-(fluoromethyl)azetidin-1-yl]prop-1-enyl]phenyl]-4-methyl-2H-chromen-7-ol, or pharmaceutically acceptable salts thereof. Also provided are processes for their preparation. Also provided for is the use of these compounds for the treatment of diseases which are related to modulation of estrogen receptors, such as ER-positive breast cancer.
    Type: Application
    Filed: July 22, 2020
    Publication date: January 28, 2021
    Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
    Inventors: Rajan Kumar PAL, Biswajit SAMANTA, Jayraj Dilipbhai ARADHYE, Sandeep Pankajkumar PATHAK, Kaushik Dhanjibhai PRAJAPATI, Bhavesh Mohanbhai PANCHAL, Trinadha Rao CHITTURI